Home ›
Trademark Categories ›
Pharmaceuticals ›
2001 ›
YD ›
YDILAZ
Trademark search for:
YDILAZ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-11-29 — Application filed
2016-12-02 — Application filed
2016-12-05 — Application filed
2017-03-03 — Assigned to examiner
2017-03-06 — Final disposition recorded
2017-03-06 — Final disposition recorded
2017-03-06 — Final disposition recorded
2017-03-16 — Office action issued
2017-03-16 — Correspondence received in law office
2017-03-17 — Teas/email correspondence entered
2017-04-07 — Suspension letter written
2017-04-07 — Letter of suspension e-mailed
2017-04-07 — Notification of letter of suspension e-mailed
2017-06-20 — Teas response to suspension inquiry received
2017-07-25 — Assigned to lie
2017-07-29 — Correspondence received in law office
2017-07-29 — Teas/email correspondence entered
2017-08-07 — Approved for pub - principal register
2017-08-23 — Notification of notice of publication e-mailed
2017-09-12 — Published for opposition
2017-09-12 — Official gazette publication confirmation e-mailed
2017-11-28 — Registered-principal register
2022-11-28 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-06-07 — Cancelled sec. 8 (6-yr)
2024-06-07 — Final status recorded
Owner Information
PHARMA MAR S.A.
Madrid ES
PHARMA MAR S.A.
Madrid ES
PHARMA MAR S.A.
Madrid ES
Correspondent
NEIL F. GREENBLUM GREENBLUM & BERNSTEIN, P.L.C. 1950 ROLAND CLARKE PL RESTON, VA 20191-1411 UNITED STATES
Filing Details
Filing Date:
2016-11-29
Status Date:
2024-06-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.